EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination

Shashi N Kapadia iD, Ashly E Jordan iD, Benjamin J Eckhardt, David C Perlman

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciad503 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Shashi N Kapadia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Hepatitis C, RNA, Viral, Hepacivirus, Point-of-Care Testing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) elimination is an important global public health goal. However, the United States is not on track to meet the World Health Organization's 2030 targets for HCV elimination. Recently, the White House proposed an HCV elimination plan that includes point-of-care (POC) HCV RNA testing, which is currently in use in many countries but is not approved in the United States. POC HCV RNA testing is crucial for implementing community-based testing and for enabling test-and-treat programs, assessing cure, and monitoring for reinfection. Here, we review the status of POC HCV RNA testing in the United States, discuss factors that are needed for successful implementation, and issue specific public health and policy recommendations that would allow for the use of POC HCV RNA testing to support HCV elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CRNA, ViralHepacivirusPoint-of-Care TestingDisease EradicationHumansUnited StatesPoint-of-Care Systems

Stichwörter der Autor:innen

hepatitis Claboratory testingmolecular diagnosticspoint-of-care testing

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.
  • Center for Drug Use and HIV/HCV Research, New York, New York, USA.
  • Division of Infectious Diseases, New York University School of Medicine, New York, New York, USA.
  • Division of Infectious Diseases, Icahn School of Medicine at Mt Sinai, New York, New York, USA.

ORCID-Profile: Shashi N Kapadia, Ashly E Jordan

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Kapadia, S. N., Jordan, A. E., Eckhardt, B. J., & Perlman, D. C. (2024). The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad503

Vancouver

Kapadia SN, Jordan AE, Eckhardt BJ, Perlman DC. The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad503

BibTeX
@article{Kapadia2024,
  author = {Kapadia, Shashi N and Jordan, Ashly E and Eckhardt, Benjamin J and Perlman, David C},
  title = {The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciad503}
}
Kostenlos starten →